Nationally, venture capital investments into life sciences firms totaled $4.9 billion during the first nine months of 2013, down 30 percent from the same period in 2008, according to data from Thomson Reuters and PricewaterhouseCoopers. In Indiana, life sciences firms raised $21 million during the first nine months of the year, far lower than any year since 2003.
When Gov. Mike Pence tries next month to negotiate a Medicaid expansion deal in a meeting with the Obama administration, it will be a clash of the conservative and liberal approaches to fighting poverty.
Careers in science, technology, engineering and math—typically referred to as STEM fields—have surged in growth compared to other careers in Marion and Hamilton counties. But the rest of Indiana has barely budged from the early 2000s.
Obamacare has officially arrived, but both conservatives and liberals are calling it awful. That means the real debate over health reform is just beginning.
In the Christmas spirit of hope, I’m offering a reading list of several optimistic reports about health care reform—even though many of my recent posts, and the mood of the country in general, have been decidedly downbeat.
The Obama administration has been releasing more price and quality information, but it is coming in a rather useless form for patients. That’s a problem for the prospects of consumer-driven health care.
There is good evidence that new technology deployed via new methods of medicine across the entire health care system can reduce the need for physicians. But there are too many barriers for such changes to occur in time to cut off the surge in demand brought on by Obamacare.
A new Medicaid expansion deal with the Republican governor of Iowa OK’d a cost-sharing requirement similar to what Indiana Gov. Mike Pence wants. But the Obama administration says it won’t extend that deal as low as Pence would like to go.
Eli Lilly and Co. on Wednesday will fall off its second “patent cliff” in as many years as its best-selling drug Cymbalta sees its U.S. patents expire.
Based on some very rough assumptions, I calculate that Hoosiers could see premiums 14 percent to 28 percent higher in 2015, due in part to low enrollment in the Obamacare exchanges in 2014.
In response to insurers’ “zero-premium” strategy, hospitals figure out their own way to game the tax subsidies available in the new Obamacare exchanges: pay premiums for their patients.
IU Health is working with a hospital-based health plan in Pittsburgh that is now directly challenging the Blue Cross health plan there. Could the same thing happen here?
In spite of President Obama’s promises that if you like your doctor, you can keep your doctor, the president’s health reform law is spurring health insurers to make him a liar on that point too.
A new survey shows Hoosiers don’t like the Affordable Care Act, most would like to see it repealed, and by a nearly 2-to-1 margin, they support Pence’s handling of the question of expanding Medicaid.
The agreement is one of the largest ever for the medical device industry. It resolves an estimated 8,000 cases of patients who had to have the company’s metal ball-and-socket hip implant removed or replaced. The implants were made by J&J’s Indiana-based DePuy unit.
It’s no secret the growth of the U.S. economy slowed in the 2000s after the go-go decade preceding it. But the U.S. health care system—hospitals, doctors, drug companies, device makers and health insurers—apparently didn’t get that memo.
The Affordable Care Act was designed to restructure the individual insurance market into a true insurance risk pool. President Obama should stop pretending those changes won’t affect everyone in the individual market, whether they want it to or not.
The days of lone-wolf researchers shouting ‘Eureka’ are over.
Obamacare put an end to health insurers’ worst methods for avoiding risk. But that doesn’t mean insurers have ended their risk-shifting ways. Not at all.
